MDXG
MIMEDX GROUP, INC.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Apr 16 ▼ MiMedx Group announced a cost reduction initiative including the eli…
- Jun 2 Mimedx Group, Inc. v. Surgenex, LLC
- Oct 16 ▼ MiMedx Group disclosed that it and Sanara MedTech each received a Se…
- Oct 28 ▼ MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M,…
- Oct 28 Contract: MIMEDX Announces $25 Million Patent License Agreement
- Oct 28 ▲ Earnings: MDXG Q3 2026 Earnings: EPS $-0.01 (+26.5% vs est)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q3 2026: 30 added (0 new), 14 trimmed or exited.
- AnalystsBULLISH
10 of 11 rate it Buy or better.
- Short sellersSTEADY
Short interest −3.2% to 8.97M shares. 4.3 days to cover, ≈6.2% of shares.
- TrendDOWNTREND
25% below its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Oct 22.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| AMERICAN CENTURY COMPANIES INC | DOUBLED | $8.9M |
| MARSHALL WACE, LLP | DOUBLED | $5.8M |
| Creative Planning | ADD | $4.0M |
| UBS Group AG | DOUBLED | $3.7M |
| JANE STREET GROUP, LLC | TRIM | $1.4M |
| Quantinno Capital Management LP | DOUBLED | $1.4M |
| PRINCIPAL FINANCIAL GROUP INC | ADD | $1.2M |
| BARCLAYS PLC | ADD | $843.2K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analysts| Date | Firm | Rating |
|---|---|---|
| Aug 27, 2026 | Craig-Hallum MAINTAIN | Buy |
| Aug 17, 2026 | Cantor Fitzgerald REITERATE | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
DOUG RICE Chief Financial Officer Jul 2, 2026 | TAX W/H | $50.4K |
Maersk-Moller Kimberly Chief Commercial Officer Jun 24, 2026 | TAX W/H | $75.9K |
PUHY DOROTHY E Director Jun 10, 2026 | AWARD | $185.3K |
BIERMAN JAMES L Director Jun 10, 2026 | AWARD | $185.3K |
Olson Tiffany Director Jun 10, 2026 | AWARD | $185.3K |
HAWKINS WILLIAM A Director Jun 10, 2026 | AWARD | $185.3K |
Newton Todd Director Jun 10, 2026 | AWARD | $185.3K |
Maersk-Moller Kimberly Chief Commercial Officer Mar 13, 2026 | TAX W/H | $29.6K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
9 filings · 1 press release · 1 bullish · 4 bearish · 1 mixed · 3 neutral- NEUTRAL SC 13GNov 12, 2026
Trigran Investments, Inc. and its controlling shareholders disclosed a 5.1% passive stake in…
Monitor for any amendment to SC 13D if Trigran's intent shifts from passive to active, particularly given the company's recent revenue decline. The 5.1% stake is just above the 5% threshold…
- BEARISH 8-KOct 28, 2026
MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in…
The Wound segment's 71% revenue decline from Medicare reimbursement changes is the dominant driver of the results, and the lowered 2026 guidance suggests no near-term recovery. Watch for FTC…
- BEARISH PRESS-RELEASEOct 28, 2026
MiMedx reported Q3 2026 net sales of $62M, down 45% YoY from $114M, driven by a 71% decline in…
The 71% Wound Care revenue collapse from Medicare changes is the dominant driver, and the lowered 2026 guidance suggests no near-term recovery. Monitor Q4 2026 for sequential Wound Care…
- BULLISH PRESS RELEASEOct 28, 2026
MiMedx Group entered into a patent license agreement with an unnamed wound care competitor…
The $25 million license agreement provides a predictable, multi-year cash stream that is material relative to MiMedx's $561 million market cap. Monitor for future installments and any updates on the…
All MDXG filing & press-release reports (10)
- SC 13G reportNov 12, 2026
- 8-K reportOct 28, 2026
- PRESS-RELEASE reportOct 28, 2026
- PRESS-RELEASE reportOct 28, 2026
- 425 reportOct 16, 2026
- 8-K reportOct 16, 2026
- COURT-RULING reportJun 2, 2026
- DEFA14A reportApr 29, 2026
- PRESS-RELEASE reportApr 22, 2026
- 8-K reportApr 16, 2026